Wednesday, June 24, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 896 of 1,261
  1. US 8324236

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  2. US 8324207

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  3. US 8324368

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Alnylam Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  4. US 8324383

    Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile

    Takeda Pharmaceutical Company Limited · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  5. US 8324258

    F1F0-ATPase inhibitors and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  6. US 8324220

    Pyrimidines useful as modulators of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  7. US 8324210

    Pterin analogs

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  8. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  9. US 8324192

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  10. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  11. US 8324200

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  12. US 8324165

    Compositions for treating arthritis comprising HG1023575 polypeptide

    Five Prime Therapeutics, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  13. US 8323686

    Nanostructures suitable for sequestering cholesterol and other molecules

    Northwestern University · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  14. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  15. US 8323962

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  16. US 8323679

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  17. US 8323706

    Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  18. US 8324366

    Compositions and methods for delivering RNAI using lipoproteins

    Alnylam Pharmaceuticals, Inc. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  19. US 8323635

    Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

    GENERAL REGENERATIVES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  20. WO 2012159962

    COMPOSITION PHARMACEUTIQUE CONTENANT DU KÉTOPROFÈNE

    AVENTIS PHARMA SA [FR] · Granted Nov 29, 2012 · Expires Nov 24, 2032

    granted
  21. DE 102011076653

    Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure

    ACINO AG [DE] · Granted Nov 29, 2012 · Expires Nov 24, 2032

    granted
  22. US 2012301425

    NOVEL ANTITUMORAL USE OF CABAZITAXEL

    GUPTA SUNIL [US] · Granted Nov 29, 2012 · Expires Nov 24, 2032

    granted
  23. US 8318425

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  24. US 8318467

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.